Pletal is a synthetic phosphodiesterase 3 inhibitor used clinically to improve intermittent claudication in peripheral arterial disease. It exerts its pharmacological effects by increasing intracellular cyclic adenosine monophosphate levels in platelets and vascular smooth muscle cells leading to vasodilation and reduced platelet aggregation. The drug selectively blocks pde3 enzymes which are responsible for hydrolyzing camp thereby sustaining elevated camp concentrations that mediate its antiplatelet and vasodilatory actions. Through this mechanism Pletal enhances microcirculatory flow and alleviates symptoms associated with peripheral vascular insufficiency. Its therapeutic role is specifically directed at patients with peripheral artery disease who experience exercise induced leg pain and cramping. The overall pharmacological profile reflects dose dependent inhibition of pde3 with secondary effects on vascular tone and hemorheology.

Pletal is a prescription drug marketed for improving blood flow in peripheral artery disease. It works by blocking phosphodiesterase-3 enzymes in platelets and vascular smooth muscle cells. This inhibition raises intracellular camp levels, which reduces platelet aggregation and relaxes blood vessels. The combined antiplatelet effect and vasodilation increase oxygen delivery to muscles during exertion. Clinically the medication is used to raise walking distance and reduce symptoms of intermittent claudication. By selectively targeting pde3, Pletal provides a dual mechanism that addresses both clot formation and vessel resistance.

The medication Pletal may cause headache in some patients. Some users report mild diarrhea or stomach discomfort. Palpitations or an increased heart rate can occur occasionally. Dizziness or light headedness may be experienced especially when standing quickly. Flushing or a warm sensation in the skin is possible. Trouble sleeping or mild insomnia can happen in certain individuals. Rarely upper respiratory infections or cough have been reported.

Headache may occur in some patients taking Pletal. Dizziness is a frequently reported symptom. Flushing or warmth in the face can happen occasionally. Nausea and abdominal discomfort are also possible. Swelling of the ankles or lower legs may develop in rare cases. Fatigue is sometimes noted during treatment. Some individuals experience increased heart rate. Most side effects are mild and tend to improve over time.